
 [
{
"symbol" : "524804",
"exchange" : "BOM",
"id": "678179",
"t" : "524804",
"e" : "BOM",
"name" : "Aurobindo Pharma Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524804"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524804"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524804"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "13.72%",
"annual" : "15.25%",
"ttm" : "15.08%"
},
{
"title" : "Operating margin",
"recent_quarter" : "20.47%",
"annual" : "20.01%",
"ttm" : "19.91%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "22.85%",
"ttm" : "23.03%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "14.31%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "27.63%",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "13,982",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "+13.30",
"l" : "615.15",
"cp" : "2.21",
"ccol" : "chg",
"op" : "602.00",
"hi" : "616.65",
"lo" : "596.75",
"vo" : "166,192.00",
"avvo" : "",
"hi52" : "808.95",
"lo52" : "504.00",
"mc" : "360.71B",
"pe" : "14.84",
"fwpe" : "",
"beta" : "",
"eps" : "41.44",
"dy" : "0.41",
"ldiv" : "1.00",
"shares" : "585.90M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "678179",
"name" : "Aurobindo Pharma Ltd",
"t" : "524804",
"e" : "BOM",
"l" : "615.15",
"c" : "+13.30",
"mc" : "360.71B",
"cp" : "2.21",
"ccol" : "chg"
}
,
{
"id" : "11999111",
"name" : "Ranbaxy Laboratories Limited",
"t" : "RANBAXY",
"e" : "NSE",
"l" : "860.40",
"c" : "",
"mc" : "365.99B",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "472496922152391",
"name" : "Laurus Labs Ltd",
"t" : "LAURUSLABS",
"e" : "NSE",
"l" : "519.10",
"c" : "+3.40",
"mc" : "54.99B",
"cp" : "0.66",
"ccol" : "chg"
}
,
{
"id" : "5391783",
"name" : "Cipla Ltd",
"t" : "CIPLA",
"e" : "NSE",
"l" : "589.50",
"c" : "-6.15",
"mc" : "475.86B",
"cp" : "-1.03",
"ccol" : "chr"
}
,
{
"id" : "16070884",
"name" : "Bliss GVS Pharma Limited",
"t" : "BLISSGVS",
"e" : "NSE",
"l" : "198.00",
"c" : "+8.55",
"mc" : "20.47B",
"cp" : "4.51",
"ccol" : "chg"
}
,
{
"id" : "14985096",
"name" : "Coral Laboratories Ltd",
"t" : "524506",
"e" : "BOM",
"l" : "591.00",
"c" : "+0.60",
"mc" : "2.11B",
"cp" : "0.10",
"ccol" : "chg"
}
,
{
"id" : "4270139",
"name" : "Sun Pharma Advanced Research Company",
"t" : "SPARC",
"e" : "NSE",
"l" : "439.80",
"c" : "-18.20",
"mc" : "111.24B",
"cp" : "-3.97",
"ccol" : "chr"
}
,
{
"id" : "11079050",
"name" : "BDH Industries Ltd",
"t" : "524828",
"e" : "BOM",
"l" : "77.00",
"c" : "+1.15",
"mc" : "444.19M",
"cp" : "1.52",
"ccol" : "chg"
}
,
{
"id" : "478315",
"name" : "Wintac Ltd",
"t" : "524758",
"e" : "BOM",
"l" : "236.50",
"c" : "-3.50",
"mc" : "2.37B",
"cp" : "-1.46",
"ccol" : "chr"
}
,
{
"id" : "16302121",
"name" : "Fresenius Kabi Oncology Ltd",
"t" : "FKONCO",
"e" : "NSE",
"l" : "132.45",
"c" : "-0.05",
"mc" : "20.96B",
"cp" : "-0.04",
"ccol" : "chr"
}
,
{
"id" : "6355153",
"name" : "Sequent Scientific Limited",
"t" : "512529",
"e" : "BOM",
"l" : "83.50",
"c" : "+1.70",
"mc" : "20.53B",
"cp" : "2.08",
"ccol" : "chg"
}
]
, "summary" : [{
"address": "Water Mark Building,, Plot No. 11 Survey no.9, Kondapur, Hitech City Hyderabad,Telangana, HYDERABAD, 500084, India",
"phone": "+91-40-66725000",
"fax": "+91-40-23741080",
"url": "http:\u002F\u002Fwww.aurobindo.com",
"overview" : "Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic\u002Fproduct areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries."
} ]
, "management" : [
{
"name" : "K. Nityananda Reddy",
"age" : "59",
"title" : "Whole-Time Vice Chairman of the Board"
}
,
{
"name" : "Santhanam Subramanian",
"title" : "Chief Financial Officer"
}
,
{
"name" : "B. Adi Reddy",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "N. Govindarajan",
"age" : "49",
"title" : "Managing Director, Executive Director"
}
,
{
"name" : "M. Madan Mohan Reddy",
"age" : "57",
"title" : "Whole-Time Director"
}
,
{
"name" : "P. Sarath Chandra Reddy",
"age" : "32",
"title" : "Whole-Time Director"
}
,
{
"name" : "M. Sivakumaran",
"age" : "74",
"title" : "Whole-Time Director"
}
,
{
"name" : "K. Ragunathan",
"age" : "54",
"title" : "Non-Executive Independent Chairman of the Board"
}
,
{
"name" : "P.V. Ramaprasad Reddy",
"age" : "59",
"title" : "Non-Executive Director, Promoter"
}
,
{
"name" : "Savita Mahajan",
"age" : "58",
"title" : "Additional Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
